antipyrine has been researched along with acetylglucosamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Deguchi, K; Kawai, H; Liu, N; Lukic-Panin, V; Matsuura, T; Shang, J; Tian, F; Yamashita, T; Zhang, X | 1 |
| Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kono, S; Liu, N; Liu, W; Omote, Y; Yamashita, T; Yunoki, T | 1 |
| Benetti, E; Chegaev, K; Chiazza, F; Collino, M; Cutrin, JC; Fruttero, R; Lazzarato, L; Rogazzo, M | 1 |
3 other study(ies) available for antipyrine and acetylglucosamine
| Article | Year |
|---|---|
Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.
Topics: Acetylglucosamine; Animals; Antipyrine; Blood-Brain Barrier; Brain Injuries; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Drug Interactions; Edaravone; Endothelial Cells; Fibrinolytic Agents; Free Radical Scavengers; Gene Expression Regulation; In Vitro Techniques; Lipid Peroxidation; Male; Membrane Proteins; Nerve Tissue Proteins; Occludin; Oxidative Stress; Rats; Rats, Wistar; Tissue Plasminogen Activator | 2010 |
Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.
Topics: Acetylglucosamine; Animals; Antipyrine; Astrocytes; Brain Ischemia; Cell Proliferation; Disease Models, Animal; Edaravone; Free Radical Scavengers; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Male; Pericytes; Quinolines; Rats; Rats, Wistar; Receptor, Platelet-Derived Growth Factor beta; Reperfusion; Time Factors; Tissue Plasminogen Activator | 2014 |
A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.
Topics: Acetylglucosamine; Acute-Phase Proteins; Animals; Antipyrine; Creatinine; Disease Models, Animal; Edaravone; Free Radical Scavengers; Ischemia; Kidney; Lipid Peroxidation; Lipocalin-2; Lipocalins; Male; Malondialdehyde; Nitric Oxide Donors; Oxadiazoles; Oxidative Stress; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Urea | 2015 |